Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Sale of 5,124 EDIT shares, $15.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 5,124 | $15.6K |
| Jun 5, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 15,380 | $41.5K |
| Mar 16, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 1,015,200 | n/a |
| Mar 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 5,394 | $10.9K |
| Dec 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 5,603 | $12.1K |
| Sep 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 5,592 | $14.5K |
| Jun 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 15,192 | $26.2K |
| Mar 27, 2025 | Editas Medicine, Inc. (EDIT) | Grant/Award | 828,000 | n/a |
| Mar 5, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 16,632 | $28.5K |
| Dec 5, 2024 | Editas Medicine, Inc. (EDIT) | Sale | 1,618 | $3.4K |